Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
23 hedge funds and large institutions have $3.84M invested in Celgene Corporation Contingent Value Rights in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
5% more funds holding
Funds holding: 22 → 23 (+1)
20% less capital invested
Capital invested by funds: $4.81M → $3.84M (-$972K)
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell & Co
New York
|
+$854K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$57.2K |
| 3 |
MC
Muhlenkamp & Co
Wexford,
Pennsylvania
|
+$32.2K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.71K |
| 5 |
LNWWM
Laird Norton Wetherby Wealth Management
San Francisco,
California
|
+$333 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$159K |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$85.8K |
| 3 |
State Street
Boston,
Massachusetts
|
-$57K |
| 4 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$28.9K |
| 5 |
Morgan Stanley
New York
|
-$23.2K |
CELGZ Hedge Fund Activity: Q2 2015 in Review
23 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q2 2015, worth a combined $3.84M — down 20% from $4.81M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CELGZ positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 6 trimmed.
The largest buyer was Cannell & Co, opening a new position worth an estimated $854K. The largest seller was Millennium Management, cutting an estimated $159K.
- 23 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q2 2015, up from 22 in Q1 2015.
- Funds reported $3.84M of Celgene Corporation Contingent Value Rights stock for Q2 2015, down 20% quarter-over-quarter.
- 4 funds opened new Celgene Corporation Contingent Value Rights positions in Q2 2015 and 2 closed out, a net change of +2 holders.
- The largest Celgene Corporation Contingent Value Rights buyer in Q2 2015 was Cannell & Co, an estimated $854K added.
- The largest Celgene Corporation Contingent Value Rights seller in Q2 2015 was Millennium Management, an estimated $159K sold.
Based on aggregated 13F filings for Q2 2015.